--- title: "NRX Therapeutics (NRXP.US) — Financial Reports" type: "Symbol" locale: "en" url: "https://longbridge.com/en/quote/NRXP.US/norm.md" symbol: "NRXP.US" name: "NRX Therapeutics" parent: "https://longbridge.com/en/quote/NRXP.US.md" datetime: "2026-06-14T06:42:50.092Z" locales: - [en](https://longbridge.com/en/quote/NRXP.US/norm.md) - [zh-CN](https://longbridge.com/zh-CN/quote/NRXP.US/norm.md) - [zh-HK](https://longbridge.com/zh-HK/quote/NRXP.US/norm.md) --- # NRX Therapeutics (NRXP.US) — Financial Reports ## Income Statement (USD) | Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | | --- | --- | --- | --- | --- | --- | | EPS | -0.0442 | 0.0124 | -0.2649 | -0.9803 | -0.3359 | | ROE | 38.45% | -6.91% | 76.78% | 231.42% | 91.14% | | Revenue | 1.07M | 983000.00 | 242000.00 | - | - | | Net income | -1.43M | 360000.00 | -5.89M | -17.58M | -5.51M | | Operating income | -4.75M | -4.59M | -4.12M | -3.73M | -3.75M | | Gross margin | 40.92% | 58.49% | 59.92% | - | - | | Net margin | -133.90% | 36.62% | -2433.88% | - | - | | Profit quality | - | - | - | - | - | ## Balance Sheet (USD) | Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | | --- | --- | --- | --- | --- | --- | | A&L | 11.90M | 12.96M | 15.00M | 4.84M | 7.59M | | Leverage | -0.8615 | -0.8130 | -0.5823 | -0.1358 | -0.3017 | | BVPS | -0.4132 | -0.5027 | -0.9304 | -1.83 | -1.47 | | Turnover | 0.2353 | 0.1475 | 0.0249 | - | - | | Cash & STI | 6.71M | 7.80M | 7.18M | 2.91M | 5.55M | | Inv & Rec | - | - | - | - | - | | LT assets | 1.20M | 696000.00 | 419000.00 | 8000.00 | - | | Net debt | -5.78M | -7.17M | 3.07M | 6.94M | 2.85M | ## Cash Flow Statement (USD) | Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | | --- | --- | --- | --- | --- | --- | | Operating CF | -4.29M | -3.71M | -2.89M | -4.03M | -3.48M | | Investing CF | -213000.00 | -249000.00 | -2.56M | - | - | | Financing CF | 3.42M | 4.58M | 9.73M | 1.39M | 7.58M | | Free CF | -5.68M | -1.25M | -5.65M | 4.01M | 1.56M | | OCF coverage | - | -2411.04% | - | -5443.24% | -1087.50% | | Repaid & issued | - | 0.0000 | -225000.00 | 452000.00 | - | | CapEx | - | - | - | - | - |